About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials | 6,582 Studies Recruiting

Clinical TrialsLymphoma

Lymphoma Clinical Trials

Browse 6,582 clinical trials for lymphoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 181-200 of 6,582 trials

Active not recruitingStudy Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT)SC291-101 is a Phase 1 study to evaluate SC291 safety and tolerability, anti-tumor activity, cellular kinetics, immunogenicity, and exploratory biomarkers.NCT05878184·Duarte, California and 9 others TerminatedA Study of DPX-Survivac Vaccine Therapy in Patients With Recurrent Survivin-expressing DLBCLThis phase 2 study was designed to assess the efficacy and safety of DPX-Survivac plus low dose cyclophosphamide in up to 24 subjects with recurrent diffuse large B-cell lymphoma…NCT02323230·Ottawa, Ontario and 1 other CompletedS0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver DysfunctionRATIONALE: Drugs used in chemotherapy work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00049400·Duarte, California and 22 others

Related Searches

hodgkintrials non-hodgkintrials

Data from ClinicalTrials.govTerms

UnknownClinical Study of SL19+22 CAR-T Cells for Relapsed or Refractory Non-Hodgkin LymphomaTo evaluate the safety and efficacy of SL19+22 in patients with relapsed or refractory non-Hodgkin's lymphoma.NCT05206071·Langfang, Hebei

CompletedStudy of GTx-024 on Muscle Wasting (Cachexia) Cancer.The purpose of this study is to assess if Gtx-024 is effective in increasing lean body mass in subjects with muscle wasting related to cancer.NCT00467844·Anchorage, Alaska and 51 others

CompletedIdentification of Occupational Exposures in Acute Hematologic MalignancyLymphoid hemopathies are a group of malignant haematological disorders characterized by clonal proliferation of cells of the lymphoid line.NCT03316209·Bordeaux and 6 others

TerminatedEverolimus and Bortezomib in Treating Patients With Relapsed or Refractory LymphomaRATIONALE: Everolimus and bortezomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.NCT00671112·Cleveland, Ohio

TerminatedBeta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell TransplantationRATIONALE: Monoclonal antibodies such as rituximab can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells.NCT00087009·New York, New York

Active not recruitingIsatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and LymphomaThe purpose of this study is to see if Isatuximab can alter the immune system in patients with multiple myeloma or lymphoma upon recovery from the autologous stem cell…NCT05346809·Detroit, Michigan and 1 other

UnknownPhase 1/2 Study of the Combination of Pixantrone, Etoposide, Bendamustine and, in CD20 Positive Tumors, Rituximab in Patients With Relapsed Aggressive Non-Hodgkin Lymphomas of B- or T-cell Phenotype - the P[R]EBEN StudyThis is a phase 1/2 open label study to assess the safety and efficacy of pixantrone in combination with bendamustine, etoposide and , for CD20 positive B-cell lymphomas…NCT02678299·Aarhus and 17 others

RecruitingEvaluation of CO-OP for Adolescents With Mild Intellectual DisabilityIntellectual disability (ID) affects a person throughout life and includes difficulties to manage what is expected in everyday life based on age.NCT06691698·Kristianstad, Skåne County and 1 other

CompletedStudy to Assess Drug Levels and Safety of BMS-986278 in Healthy Participants and Participants With Different Degrees of Hepatic ImpairmentThe purpose of this study is to assess the drug levels and safety of BMS-986278 in participants with mild, moderate, and severe Hepatic Impairment (HI), and in matched healthy…NCT06425198·Miami Lakes, Florida and 3 others

RecruitingAnti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)Autologous, unselected CD3+ lymphocytes collected from apheresis, transfected with a lentiviral vector containing a 2nd generation chimeric antigen receptor (CAR) consisting of a…NCT03938987·Calgary, Alberta and 5 others

TerminatedStudy of GS-0189 (Formerly FSI-189) as Monotherapy and in Combination With Rituximab in Participants With Relapsed/Refractory Non-Hodgkin LymphomaThe primary objective of this study is to determine the safety and tolerability of GS-0189 (formerly FSI-189) as monotherapy and in combination with rituximab in participants with…NCT04502706·Birmingham, Alabama and 4 others

CompletedGabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use DisordersThis research study evaluates the effects of an FDA-approved medication Gabapentin in individuals with Bipolar Disorder who smoke marijuana.NCT05064319·Charleston, South Carolina

RecruitingMosunetuzumab and Polatuzumab Vedotin for the Treatment of Patients With Relapsed or Refractory Grade 1-3a Follicular LymphomaThis phase II trial tests how well mosunetuzumab and polatuzumab vedotin works in treating patients with grade 1-3a follicular lymphoma that has come back after a period of…NCT06453044·Duarte, California and 1 other

UnknownUmbilical Cord Blood and Placental Blood Transplantation in Treating Patients With Hematologic Cancer or Aplastic AnemiaRATIONALE: Umbilical cord blood or placental blood transplantation may be able to replace immune cells that were destroyed by the chemotherapy or radiation therapy that was used…NCT00008164·New York, New York

CompletedBlinatumomab Plus HLA-Mismatched Cellular Therapy for Relapsed/Refractory CD19+ ALLSingle center Phase 1 dose escalation trial of the combination of standard-of-care blinatumomab plus Haplo-Mismatched Cellular Therapy (HMCT).NCT03751709·Los Angeles, California

UnknownRelmacabtagene Autoleucel as First-Line Therapy for High-Risk Large B-Cell LymphomaThe primary objective of this study is to estimate the efficacy of Relmacabtagene Autoleucel in participants with high-risk large B-cell lymphoma.NCT05590221·Beijing, Beijing Municipality and 3 others

UnknownThalidomide Maintenance Treatment in DLBCLThis is a randomized, multi-center,phase III study to evaluate the ability of thalidomide maintenance therapy to prolong relapse-free survival in diffuse large B cell…NCT03016000·Guangzhou, Guangdong

PreviousPage 10 of 330Next